In: Nursing
Sl. No |
Conventional Drug Delivery |
Sustained Drug Delivery |
|
1. |
Definition |
The conventional drug generally result in relatively rapid drug absorption and onset of accompanying pharmacodynamic effects, delivery system is the absorption of the drug across a biological membrane. |
Sustained Release Drug Delivery System (SRDDS) is designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects. |
2. |
Kinetics of the drug |
The pharmacokinetics is divided into Absorption: - cellular levels, mouth, stomach, duodenum Metabolism: - inside the cells, short half life. Distribution: - receptors on the biological membrane Excretion: - through venous circulation |
The pharmacokinetics is divided into Absorption: - duodenum, lower parts of jejunum and ileum. Metabolism: - liver, with specific half life Distribution: - circulatory system Excretion: - through GI & kidney |
3. |
Drug Localisation Mechanism |
Drug is localised to the area of application and sometimes localised to the area of affect |
These drugs are coated drugs or programmed slow release drugs which act on larger areas of localisation and dynamically are more dominant than other drugs |
2. What are the limitations and problems associated with using a sustained dosage form?
1. Any over dosage is fatal
2. It does not permit prompt termination of therapy.
3. Less flexibility in dose adjustment.
4. These dosage forms are designed on the basis of average biological half-life, but in these they have long half life leading to larger discrepancies.
5. They are costly.